Bilimsel çalışmalar

Prof. Dr. İbrahim Yıldız

113 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer.

    PubMed, 2015

    PMID 26011336 1 atıf (Europe PMC) Kaynak: OpenAlex

  2. Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: an Izmir Oncology Group (IZOG) study.

    PubMed, 2015

    PMID 26416056 1 atıf (Europe PMC) Kaynak: OpenAlex

  3. Can basal neutrophil/ lymphocytes ratio predict clinical outcome of melanoma patients?

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e20108 Kaynak: OpenAlex

  4. P-049 First-line cisplatin plus bolus 5- Fluorouracil combination in patients with locally advanced and metastatic esophageal cancer

    Annals of Oncology, 2015

    DOI 10.1093/annonc/mdv233.49 Kaynak: OpenAlex

  5. First-line cisplatin plus bolus 5- Fluorouracil combination in patients with locally advanced and metastatic esophageal cancer(Izmir Oncology Group Study)

    Acta Oncologica Turcica, 2015

    DOI 10.5505/aot.2015.92408 Kaynak: OpenAlex

  6. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

    World Journal of Urology, 2014

    DOI 10.1007/s00345-014-1462-7 PMID 25515319 25 atıf (Europe PMC) Kaynak: OpenAlex

  7. Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.17.7119 PMID 25227800 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors

    Medical Oncology, 2014

    DOI 10.1007/s12032-014-0043-3 PMID 24913808 17 atıf (Europe PMC) Kaynak: OpenAlex

  9. High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer

    Tumor Biology, 2014

    DOI 10.1007/s13277-014-1932-y PMID 24740564 17 atıf (Europe PMC) Kaynak: OpenAlex

  10. Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial.

    PubMed, 2014

    PMID 25075067 7 atıf (Europe PMC) Kaynak: OpenAlex

  11. Markers to Predict the Efficacy of Bevacizumab in the Treatment of Metastatic Colorectal Cancer

    Tumori Journal, 2014

    DOI 10.1177/1636.17888 PMID 25296585 7 atıf (Europe PMC) Kaynak: OpenAlex

  12. Anticancer Therapy for Breast Cancer Patients with Skin Metastases Refractory to Conventional Treatments

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.4.1885 PMID 24641425 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  13. Isolated Liver Metastasis of Sacrococcygeal Chordoma: Case Report and Review of the Literature

    Case Reports in Oncological Medicine, 2014

    DOI 10.1155/2014/826584 PMID 25018886 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  14. Clinical significance of serum M30 and M65 levels in patients with breast cancer

    Biomedicine & Pharmacotherapy, 2014

    DOI 10.1016/j.biopha.2014.10.021 PMID 25465151 8 atıf (Europe PMC) Kaynak: OpenAlex

  15. Effects of Tamoxifen on Premenopausal Breast Cancer Patients in Terms of Anxiety, Depression, Quality of Life and Sexual Satisfaction

    Acta Oncologica Turcica, 2014

    DOI 10.5505/aot.2014.72692 Kaynak: OpenAlex

  16. First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.7.3157 PMID 24815463 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  17. Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma

    The Anatolian Journal of Cardiology, 2014

    DOI 10.5152/akd.2014.5397 PMID 25163084 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  18. Survival Analysis of Triple Negative and Her2 Positive Breast Cancer Patients: Single Center Report

    Meme sağlığı dergisi/Meme sağlığı dergisi, 2014

    DOI 10.5152/tjbh.2014.1773 2 atıf (OpenAlex) Kaynak: OpenAlex

  19. Assessment of the Quality of Life in Turkish Breast Cancer Patients

    Meme sağlığı dergisi/Meme sağlığı dergisi, 2014

    DOI 10.5152/tjbh.2014.2012 PMID 28331674 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  20. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.

    PubMed, 2014

    PMID 24815845 2 atıf (Europe PMC) Kaynak: OpenAlex

  21. Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma

    Korean journal of urology, 2014

    DOI 10.4111/kju.2014.55.1.74 PMID 24466402 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  22. Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?

    Tumor Biology, 2014

    DOI 10.1007/s13277-013-1567-4 PMID 24390664 3 atıf (Europe PMC) Kaynak: OpenAlex

  23. Expression and Prognostic Significance of Mesothelin in Her-2-Positive and Triple-Negative Breast Cancer Patients

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu359.29 Kaynak: OpenAlex

  24. Gastric cancer with diffuse hepatic metastases and complete radiological response to triplet chemotherapy.

    PubMed, 2014

    PMID 25536630 Kaynak: OpenAlex

  25. Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e15602 Kaynak: OpenAlex

  26. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e11556 Kaynak: OpenAlex

  27. Serum inflammatory parameters as prognostic factors in patients with gastic cancer: Is serum albumin the best inflammotory biomarker predicting prognosis?

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e15002 Kaynak: OpenAlex

  28. Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.3_suppl.203 Kaynak: OpenAlex

  29. Potential Curative Role of Chemotherapy in Patients with Metastatic Colorectal Cancer Who Had Complete Response to First-line Treatment

    Acta Oncologica Turcica, 2014

    DOI 10.5505/aot.2014.08370 Kaynak: OpenAlex

  30. Onkoloji Hastalarında Hiponatremi Sıklığı ve Sağ Kalımla İlişkisi

    Hitit University Institutional Repository, 2014

    Kaynak: OpenAlex

  31. Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

    Medical Oncology, 2013

    DOI 10.1007/s12032-013-0660-2 PMID 23877872 11 atıf (Europe PMC) Kaynak: OpenAlex

  32. Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival

    Molecular and Clinical Oncology, 2013

    DOI 10.3892/mco.2013.131 PMID 24649248 53 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  33. Patterns of Complementary and Alternative Medicine Use among Turkish Cancer Patients

    Journal of Palliative Medicine, 2013

    DOI 10.1089/jpm.2012.0226 PMID 23305189 21 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  34. Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib.

    PubMed, 2013

    PMID 24065498 15 atıf (Europe PMC) Kaynak: OpenAlex

  35. Prognostic Factors Associated with the Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma

    Current Oncology, 2013

    DOI 10.3747/co.20.1596 PMID 24311955 13 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  36. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

    Cancer Chemotherapy and Pharmacology, 2013

    DOI 10.1007/s00280-013-2212-z PMID 23801282 3 atıf (Europe PMC) Kaynak: OpenAlex

  37. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy

    Medical Oncology, 2013

    DOI 10.1007/s12032-013-0679-4 PMID 23921648 22 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  38. Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.5.3255 PMID 23803112 9 atıf (Europe PMC) Kaynak: OpenAlex

  39. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

    Tumor Biology, 2013

    DOI 10.1007/s13277-013-0931-8 PMID 23784459 5 atıf (Europe PMC) Kaynak: OpenAlex

  40. Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma

    Clinical Genitourinary Cancer, 2013

    DOI 10.1016/j.clgc.2013.01.001 PMID 23391372 6 atıf (Europe PMC) Kaynak: OpenAlex

  41. Clinical significance of serum M30 and M65 levels in melanoma

    Melanoma Research, 2013

    DOI 10.1097/cmr.0b013e328363e4ab PMID 23812330 4 atıf (Europe PMC) Kaynak: OpenAlex

  42. The Role of Surgical Methods in the Treatment of Anorectal Malignant Melanoma (AMM)

    Acta chirurgica Belgica, 2013

    DOI 10.1080/00015458.2013.11680958 PMID 24494470 5 atıf (Europe PMC) Kaynak: OpenAlex

  43. Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies

    American Journal of Therapeutics, 2013

    DOI 10.1097/mjt.0b013e31828232b8 PMID 23782755 5 atıf (Europe PMC) Kaynak: OpenAlex

  44. Multiple arterial occlusions precipitated by platinum based chemotherapy in a patient with testicular seminoma

    Journal-Cardiovascular Surgery, 2013

    DOI 10.5455/jcvs.20131x12 Kaynak: OpenAlex

  45. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer

    Tumori Journal, 2013

    DOI 10.1177/030089161309900404 PMID 24326833 Kaynak: OpenAlex

  46. Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e20016 Kaynak: OpenAlex

  47. Effect of increased body mass index on time to tumor progression in metastatic unresectable colorectal cancer patients treated with bevacizumab-based therapy.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14594 Kaynak: OpenAlex

  48. Is there any prognostic importance of pretreatment serum M30 and serum M65 levels on progression-free survival of patients with metastatic renal cell carcinoma treated with first-line sunitinib?

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e15569 Kaynak: OpenAlex

  49. Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e11592 Kaynak: OpenAlex

  50. Performance status of patients is the major prognostic factor at all stages of pancreatic cancer

    International Journal of Clinical Oncology, 2012

    DOI 10.1007/s10147-012-0474-9 PMID 22996141 98 atıf (Europe PMC) Kaynak: OpenAlex